Form 483

Lemy Bread Manufacturing Corp Form 483, 2026-05-08

FDA issued a Form 483 to Lemy Bread Manufacturing Corp on 2026-05-08 with 9 public-safe observations.

483· Form 483 issuedFoods & Cosmetics9 observations

Lemy Bread Manufacturing Corp · Bayamon, United States · Issued May 8, 2026

Overview

  • 9 public-safe observations are available for this inspection.
  • 8 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

8 May 2026
21 CFR 117.10

Personnel

Cited by Rafael Gonzalez, Eva I Merced Medina

8 May 2026
21 CFR 117.35(a)

Sanitary operations - Plant maintenance

Cited by Rafael Gonzalez, Eva I Merced Medina

8 May 2026
21 CFR 117.35(a)

Sanitary operations - Plant sanitation

Cited by Rafael Gonzalez, Eva I Merced Medina

8 May 2026
21 CFR 117.35(b)(2)

Toxic chemicals - Identified, held, stored

Cited by Rafael Gonzalez, Eva I Merced Medina

8 May 2026
21 CFR 117.37

Sanitary facilities and controls

Cited by Rafael Gonzalez, Eva I Merced Medina

Inspected site

LBLemy Bread Manufacturing CorpBayamon, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 117.35(a)Cited across public-safe Form 483 observations2x
21 CFR 117.10Cited across public-safe Form 483 observations1x
21 CFR 117.35(b)(2)Cited across public-safe Form 483 observations1x
21 CFR 117.37Cited across public-safe Form 483 observations1x
21 CFR 117.4Cited across public-safe Form 483 observations1x
21 CFR 117.40Cited across public-safe Form 483 observations1x
21 CFR 117.80(c)Cited across public-safe Form 483 observations1x
21 CFR 117.93Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 9 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere